| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011PLoSO...622663P |
| P356 | DOI | 10.1371/JOURNAL.PONE.0022663 |
| P932 | PMC publication ID | 3144247 |
| P698 | PubMed publication ID | 21818362 |
| P5875 | ResearchGate publication ID | 51548921 |
| P2093 | author name string | Manoj K Chakrabarti | |
| Amit Pal | |||
| Debasis Pore | |||
| Nibedita Mahata | |||
| P2860 | cites work | Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers | Q72267131 |
| Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition | Q73507076 | ||
| Measurement of specific IgA in faecal extracts and intestinal lavage fluid for monitoring of mucosal immune responses | Q73815740 | ||
| A nonenzymatic method to isolate genomic DNA from bacteria and actinomycete | Q81362085 | ||
| Purification and characterization of an immunogenic outer membrane protein of Shigella flexneri 2a | Q84363216 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase | Q28144035 | ||
| Escherichia coli outer membrane protein A adheres to human brain microvascular endothelial cells | Q30160271 | ||
| Molecular cloning and characterization of a novel leptospiral lipoprotein with OmpA domain | Q31010467 | ||
| Identification of novel immunogenic proteins of Shigella flexneri 2a by proteomic methodologies | Q33204608 | ||
| Immunoproteomics of outer membrane proteins and extracellular proteins of Shigella flexneri 2a 2457T. | Q33226954 | ||
| Immunoproteome analysis of soluble and membrane proteins of Shigella flexneri 2457T. | Q33262196 | ||
| Functional memory B cells and long-lived plasma cells are generated after a single Plasmodium chabaudi infection in mice | Q33518486 | ||
| Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608(pCFAI) and SC608(pCFAI/LTB) that express antigens from enterotoxigenic Escherichia coli | Q33558374 | ||
| Global burden of Shigella infections: implications for vaccine development and implementation of control strategies | Q33749510 | ||
| Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602 | Q33876803 | ||
| Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans | Q34003433 | ||
| Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel | Q34006223 | ||
| Directing transition from innate to acquired immunity: defining a role for IL-6. | Q34449051 | ||
| Mucosal adjuvant properties of the Shigella invasin complex | Q34601845 | ||
| Persistence of local cytokine production in shigellosis in acute and convalescent stages. | Q35380946 | ||
| Innate secretory antibodies protect against natural Salmonella typhimurium infection | Q36227913 | ||
| Cell envelope and shape of Escherichia coli: multiple mutants missing the outer membrane lipoprotein and other major outer membrane proteins | Q36346097 | ||
| Role of neutrophils in innate immunity: a systems biology-level approach | Q36408168 | ||
| A strong antibody response to the periplasmic C-terminal domain of the OmpA protein of Escherichia coli is produced by immunization with purified OmpA or with whole E. coli or Salmonella typhimurium bacteria | Q36983204 | ||
| Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp. | Q37027574 | ||
| Mucosal adjuvanticity of a Shigella invasin complex with dna-based vaccines | Q37156758 | ||
| Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection | Q39822312 | ||
| Action of a major outer cell envelope membrane protein in conjugation of Escherichia coli K-12 | Q40033430 | ||
| Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a. | Q40123700 | ||
| Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1 | Q40150980 | ||
| The Flavobacterium psychrophilum OmpA, an outer membrane glycoprotein, induces a humoral response in rainbow trout | Q40161569 | ||
| Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis | Q40592179 | ||
| Outer membrane protein A (OmpA) binds to and activates human macrophages | Q40860980 | ||
| Identification and characterization of porins in Pseudomonas aeruginosa | Q41138048 | ||
| Outer membrane protein A of Escherichia coli O157:H7 stimulates dendritic cell activation. | Q42581877 | ||
| Growing antimicrobial resistance of Shigella isolates | Q44299913 | ||
| Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model | Q46307485 | ||
| IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis. | Q51189374 | ||
| Facilitated production of secretory IgA against Shiga toxin B subunits by intranasal application of antigen-coated polystyrene microspheres. | Q51538249 | ||
| 34 kDa MOMP of Shigella flexneri promotes TLR2 mediated macrophage activation with the engagement of NF-kappaB and p38 MAP kinase signaling. | Q53333418 | ||
| Role of Shigella flexneri 2a 34 kDa outer membrane protein in induction of protective immune response. | Q53618605 | ||
| Identification of broad cross-protective immunogens using heterogeneous antiserum-based immunoproteomic approach. | Q54401032 | ||
| Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma | Q58823347 | ||
| Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice | Q69205646 | ||
| Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model | Q70573636 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | membrane protein | Q423042 |
| Shigella flexneri | Q1644417 | ||
| P304 | page(s) | e22663 | |
| P577 | publication date | 2011-07-26 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model | |
| P478 | volume | 6 |
| Q64996406 | A murine model of diarrhea, growth impairment and metabolic disturbances with Shigella flexneri infection and the role of zinc deficiency. |
| Q40081061 | A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli. |
| Q52875091 | An Approach to Identify and Characterize a Subunit Candidate Shigella Vaccine Antigen. |
| Q38284501 | An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children |
| Q52337397 | Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex. |
| Q37335984 | Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine. |
| Q34482917 | Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo |
| Q40654441 | Construction of a recombinant Lactococcus lactis strain expressing a fusion protein of Omp22 and HpaA from Helicobacter pylori for oral vaccine development |
| Q89364697 | Cyclic OmpC peptidic epitope conjugated to tetanus toxoid as a potential vaccine candidate against shigellosis |
| Q37643320 | Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine. |
| Q39202079 | Edwardsiella tarda OmpA Encapsulated in Chitosan Nanoparticles Shows Superior Protection over Inactivated Whole Cell Vaccine in Orally Vaccinated Fringed-Lipped Peninsula Carp (Labeo fimbriatus). |
| Q51320080 | Immunization with r-Lactococcus lactis expressing outer membrane protein A of Shigella dysenteriae type-1: evaluation of oral and intranasal route of administration. |
| Q34498567 | Immunoproteomics selection of cross-protective vaccine candidates from Riemerella anatipestifer serotypes 1 and 2. |
| Q38648043 | In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity. |
| Q90947235 | In vivo delivery of pPERDBY to BALB/c mice by LacVax® DNA-I and comparison of elicited immune response with conventional immunization methods |
| Q42120657 | In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation |
| Q36309162 | In-silico design, expression, and purification of novel chimeric Escherichia coli O157:H7 OmpA fused to LTB protein in Escherichia coli |
| Q64097042 | Intranasal immunization with recombinant outer membrane protein A induces protective immune response against Stenotrophomonas maltophilia infection |
| Q39416800 | Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis |
| Q43623067 | Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice |
| Q89883532 | Oral Deliverable Mucoadhesive Chitosan-Salmonella Subunit Nanovaccine for Layer Chickens |
| Q91705205 | Oral immunization with LacVax® OmpA induces protective immune response against Shigella flexneri 2a ATCC 12022 in a murine model |
| Q38114268 | Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate |
| Q34294123 | Outer membrane protein A (OmpA) of Shigella flexneri 2a induces TLR2-mediated activation of B cells: involvement of protein tyrosine kinase, ERK and NF-κB. |
| Q35874571 | Outer membrane protein A (OmpA) of Shigella flexneri 2a links innate and adaptive immunity in a TLR2-dependent manner and involvement of IL-12 and nitric oxide |
| Q38605714 | Outer membrane proteins analysis of Shigella sonnei and evaluation of their antigenicity in Shigella infected individuals. |
| Q37105553 | Progress and pitfalls in Shigella vaccine research |
| Q38068954 | Recent progress towards development of a Shigella vaccine |
| Q41557569 | Recombinant outer membrane protein A induces a protective immune response against Escherichia coli infection in mice |
| Q39666526 | Recombinant outer membrane protein C of Aeromonas hydrophila elicits mixed immune response and generates agglutinating antibodies |
| Q89869102 | Reverse vaccinology approach for the identification and characterization of outer membrane proteins of Shigella flexneri as potential cellular- and antibody-dependent vaccine candidates |
| Q34935297 | Shigella flexneri 3a outer membrane protein C epitope is recognized by human umbilical cord sera and associated with protective activity |
| Q59798948 | Surface engineered polyanhydride-based oral Salmonella subunit nanovaccine for poultry |
| Q64244950 | Vaccination With Mouse Dendritic Cells Loaded With an IpaD-IpaB Fusion Provides Protection Against Shigellosis |
| Q34181668 | Visualization of murine intranasal dosing efficiency using luminescent Francisella tularensis: effect of instillation volume and form of anesthesia |
Search more.